Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life

Hypertension Research

Volumn 38, Issue 8, 2015, Pages 519-527

  Demura, Masashi ^a   Demura, Yosiki ^b   Takeda, Yoshiyu ^a   Saijoh, Kiyofumi ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b FUKUI PREFECTURAL HOSPITAL   (Japan)

Author keywords

Angiotensinogen; corticosteroid; DNA demethylation; DNA remethylation; visceral adipose tissue

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN; ANGIOTENSIN II; ANGIOTENSINOGEN; CCAAT ENHANCER BINDING PROTEIN; CPG OLIGODEOXYNUCLEOTIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; DNA BINDING PROTEIN; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 6; MINERALOCORTICOID RECEPTOR; RNA POLYMERASE II; TRANSCRIPTION FACTOR;

ADIPOCYTE; BINDING SITE; DEMETHYLATION; DNA BINDING; DNA METHYLATION; ENVIRONMENTAL FACTOR; GENE CONTROL; GENE EXPRESSION REGULATION; HISTONE MODIFICATION; HORMONE ACTION; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAMMARY GLAND FAT; NONHUMAN; OBESITY; PHENOTYPE; POSITIVE FEEDBACK; PROMOTER REGION; PROTEIN BINDING; REVIEW; SALT INTAKE; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; GENETICS; GENOTYPE ENVIRONMENT INTERACTION;

ANGIOTENSINOGEN; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE-ENVIRONMENT INTERACTION; HUMANS; HYPERTENSION; OBESITY; PROMOTER REGIONS, GENETIC;

EID: 84938807850     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.42     Document Type: Review

References (57)

1. Bogdarina I, Welham S, King PJ, Burns SP, Clark AJ. Epigenetic modification of the renin-Angiotensin system in the fetal programming of hypertension. Circ Res 2007; 100: 520-526.
2. Arai Y, Ohgane J, Yagi S, Ito R, Iwasaki Y, Saito K, Akutsu K, Takatori S, Ishii R, Hayashi R, Izumi S, Sugino N, Kondo F, Horie M, Nakazawa H, Makino T, Shiota K. Epigenetic assessment of environmental chemicals detected in maternal peripheral and cord blood samples. J Repro Dev 2011; 57: 507-517.
3. Nakajima T, Yamashita S, Maekita T, Niwa T, Nakazawa K, Ushijima T. The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. J Int Cancer 2009; 124: 905-910.
4. Oka D, Yamashita S, Tomioka T, Nakanishi Y, Kato H, Kaminishi M, Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention o f esophageal cancers. Cancer 2009; 115: 3412-3426.
5. Zhang Y, Yang R, Burwinkel B, Breitling LP, Brenner H. F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Env iron Health Perspect 2014; 122: 131-137.
6. Ronn T, Volkov P, Davegardh C, Dayeh T, Hall E, Olsson AH, Nilsson E, Tornberg A, Dekker Nitert M, Eriksson KF, Jones HA, Groop L , Ling C. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet 2013; 9: e1003572.
7. Miller CA, Gavin CF, White JA, Parrish RR, Honasoge A, Yancey CR, Rivera IM, Rubio MD, Rumbaugh G, Sweatt JD. Cortical DNA methylation maintains remote memory. Nat Neurosci 2010; 13: 664-666.
8. Bind MA, Zanobetti A, Gasparrini A, Peters A, Coull B, Baccarelli A, Tarantini L, Koutrakis P, Vokonas P, Schwartz J. Effects of temperature and relative humidity on DNA methylation. Epidemiol ogy 2014; 25: 561-569.
9. Petersen AK, Zeilinger S, Kastenmuller G, Romisch-Margl W, Brugger M, Peters A, Meisinger C, Strauch K, Hengstenberg C, Pagel P, Huber F, Mohney RP , Grallert H, Illig T, Adamski J, Waldenberger M, Gieger C, Suhre K. Epigenetics meets metabolomics: an epigenome-wide association study with blood serum metabolic traits. Hum Mol Genet 2014; 23: 534-545.
10. Campbell DJ. Tissue renin-Angiotensin system: sites of angiotensin formation. J Cardiovasc Pharmacol 1987; 10: S1-S8.
11. Massiera F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 2001; 15 : 2727-2729.
12. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003; 112: 83-90.
13. Rahmouni K,Mark AL,Haynes WG,Sigmund CD. Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity Am J Physiol Endocrinol Metab 2004, 286, E891-E895.
14. Yasue S, Masuzaki H, Okada S, Ishii T, Kozuka C, Tanaka T, Fujikura J, E bihara K, Hosoda K, Katsurada A, Ohashi N, Urushihara M, Kobori H, Morimoto N, Kawazoe T, Naitoh M, Okada M, Sakaue H, Suzuki S, Nakao K. Adipose tissue-specific regulation of angiotensinogen in obese h umans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens 2010; 23: 425-431.
15. Yiannikouris F, Gupte M, Putnam K, Thatcher S, Charnigo R, Rateri DL, Daugherty A, Cassis LA. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 2012; 60: 1524-1530.
16. Yiannikouris F, Karounos M, Charnigo R, Englis h VL, Rateri DL, Daugherty A, Cassis LA. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol 2012; 302: R244-R251.
17. Gur M, Elbasan Z, Yildiray Sahin D, Yildiz Koyunsever N, Seker T, Ozaltun B, Cayli M, Kocyigit A. DNA damage and oxidative status in newly diagnosed, untreated, dipper and non-dip per hypertensive patients. Hypertens Res 2013; 36: 166-171.
18. Qi Y, Zhao H, Wang Y, Wang Y, Lu C, Xiao Y, Cao J, Jia N, Wang B, Niu W. Replication of the top most significant polymorphisms from a large blood pressure genome-wide association study of northeastern Han Chinese East Asians. Hypertens Res 2014; 37: 134-138.
19. Hong YC, Kim H, Lim Y H, Yoon HJ, Kwon YM, Park M. Identification of RAS genotypes that modulate blood pressure change by outdoor temperature. Hypertens Res 2013; 36: 540-545.
20. Olearczyk J, Gao S, Eybye M, Yendluri S, Andrews L, Bartz S, Cully D, Tadin-Strapps M. Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension. Hype rtens Res 2014; 37: 405-412.
21. Ballestar E, Wolffe AP. Methyl-CpG-binding proteins. Targeting specific gene repression. Eur J Biochem 2001; 268: 1-6.
22. Wang F, Demura M, Cheng Y, Zhu A, Karashima S, Yoneda T, Demura Y, Maeda Y, Namiki M, Ono K, Nakamura Y, Sasano H, Akagi T, Yamagishi M, Saijoh K, Takeda Y. Dynamic CCAAT/e nhancer binding protein-Associated changes of DNA methylation in the angiotensinogen gene. Hypertension 2014; 63: 281-288.
23. Dickson ME, Tian X, Liu X, Davis DR, Sigmund CD. Upstream stimul atory factor is required for human angiotensinogen expression and differential regulation by the A-20C polymorphism. Circ Res 2008; 103: 940-947.
24. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A. Role of C/A polymorphism at-20 on the expression of human angiotensinogen gene. Hypertension 1999; 33: 108-115.
25. Jain S, Li Y, Patil S, Kumar A. A single-nucleotide polymorphism in human a ngiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J Mol Med (Berl) 2005; 83: 121-131.
26. Jain S, Li Y, Patil S, Kumar A. HNF-1alp ha plays an important role in IL-6-induced expression of the human angiotensinogen gene. Am J Physiol Cell Physiol 2007; 293: C401-C410.
27. Yanai K, Hirota K, Taniguchi-Yanai K, Shigematsu Y, Shim amoto Y, Saito T, Chowdhury S, Takiguchi M, Arakawa M, Nibu Y, Sugiyama F, Yagami K, Fukamizu A. Regulated expression of human angiotensinogen gene by hepatocyte nuclear factor 4 and chicken ovalbumin upstream promoter-transcription factor. J Biol Chem 1999; 274: 34605-34612.
28. Thomassin H, Flavin M, Espinas ML, Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J 2001; 20: 1974-1983.
29. Bruniquel D, Schwartz RH. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 2003; 4: 235-240.
30. Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, Carmouche RP, Benes V, Gannon F, Reid G. Transient cyclical methylation of promoter DNA. Nature 2008; 452: 112-115.
31. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, Carmouche RP, Ibberson D, Barath P, Demay F, Reid G, Benes V, Jeltsch A, Gannon F, Salbert G. Cyclic al DNA methylation of a transcriptionally active promoter. Nature 2008; 452: 45-50.
32. Thillainadesan G, Chitilian JM, Isovic M, Ablack JN, Mymryk JS, Tini M, Torchia J. TGF-beta-depe ndent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex. Mol Cell 2012; 46: 636-649.
33. Jain S,Tang X,Narayanan CS,Agarwal Y,Peter son SM,Brown CD,Ott J,Kumar A. Angiotensinogen gene polymorphism at-217 affects basal promoter activity and is associated with hypertension in African-Americans J Biol Chem 2002 277 36889-36896.
34. Guo X, Wang L, Li J, Ding Z, Xiao J, Yin X, He S, Shi P, Dong L, Li G, Tian C, Wang J, Cong Y, Xu Y. Structural insight into autoinhibition and histone H3-induced activation of DNMT3A. Nature 2014; 517: 640-644.
35. Sherman CT, Brasier AR. Role of signal transducers and activators of transcription 1 and-3 in inducible regulation of the human angiotensinogen gene by interleukin-6. Mol Endocrinol 2001; 15: 441-457.
36. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M. Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 1997; 10: 629-633.
37. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P. Increased adipose angiotensinogen gene expression in human obesity. Obes Res 2000; 8: 337-341.
38. Baudrand R, Campino C, Carvajal CA, Olivieri O, Guidi G, Faccini G, Vohringer PA, Cerda J, Owen G, Kalergis AM, Fardella CE. High sodium intake is associated with inc reased glucocorticoid production, insulin resistance and metabolic syndrome. Clin Endocrinol (Oxf) 2013; 80: 677-684.
39. Brasier AR, Ron D, Tate JE, Habener JF. Synergistic enhansons located wit hin an acute phase responsive enhancer modulate glucocorticoid induction of angiotensinogen gene transcription. Mol Endocrinol 1990; 4: 1921-1933.
40. Zhao YY, Qasba P, Siddiqui MA, Kumar A. Multiple CCAAT binding proteins regulate the expression of the angiotensinogen gene. Cell Mol Biol Res 1993; 39: 727-737.
41. Adams JM, Madden CJ, Sved AF, Stocker SD. Increased dietary salt enhances sympathoexcitatory and sympathoinhibitory responses from the rostral ventrolateral medulla. Hypertension 2007; 50: 354-359.
42. Simmonds SS, Lay J, Stocker SD. Dietary salt intake exaggerates sympathe tic reflexes and increases blood pressure variability in normotensive rats. Hypertension 2014; 64: 583-589.
43. Goossens GH, Jocken JW, Blaak EE, Schiffers PM, Saris WH, van Baak MA. Endo crine role of the renin-Angiotensin system in human adipose tissue and muscle: effect of betaadrenergic stimulation. Hypertension 2007; 49: 542-547.
44. Chang E, Perlman AJ. Multiple hormones regulate angiotensinogen messenger ribonucleic acid levels in a rat hepatoma cell line. Endocrinology 1987; 121: 513-519.
45. Ben-Ari ET, Garrison JC. Regulation of angiotensinogen mRNA accumulation in rat hepatocytes.Am J Physiol 1988; 255: E70-E79.
46. Ben-Ari ET, Lynch KR, Garrison JC. Glucocorticoids induce the accumulation of novel angiotensinogen gene transcripts. J Biol Chem 1989; 264: 13074-13079.
47. Aubert J, Darimont C, Safonova I, Ailhaud G, Negrel R. Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells. Biochem J 1997; 328: 701-70 6.
48. Turban S, Hainault I, Truccolo J, Andre J, Ferre P, Quignard-Boulange A, Guerre-Millo M. Specific increase in leptin production in obese (falfa) rat adipose cells. Biochem J 2002; 362: 113-118.
49. Kunapuli SP, Fuller GM, Kumar A. Regulation of angiotensinogen gene expression in a human hepatoma cell line. Life Sci 1987; 41: 2397-2401.
50. Campbell DJ, Bouhnik J, Coezy E, Menard J, Corvol P. Characterization of precursor and secreted forms of human angiotensinogen. J Clin Invest 1985; 75: 1880-1893.
51. Krakoff LR. Measurement of plasma renin substrate by radioimmunoassay of angiotensin. I. Concentration in syndromes associated with steroid excess. J Clin Endocrinol Metab 1973; 37: 110-117.
52. Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. Hormonal regulation of the human adipose-tissue renin-Angiotensin system: relationship to obesity and hypertension. J Hypertens 2002; 20: 965-973.
53. Schule R, Muller M, Kaltschmidt C, Renkawitz R. Many transcription factors interact synergistically with steroid receptors. Science 1988; 242: 1418-1420.
54. Takeshima H, Yamashita S, Shimazu T, Niwa T, Ushijima T. The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res 2009; 19: 1974-1982.
55. Oliver WJ,Cohen EL,Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a " no-salt" culture. Circulation 1975 52, 146-151.
56. Qiang M, Denny A, Chen J, T icku MK, Yan B, Henderson G. The site specific demethylation in the 5'-regulatory area of NMDA receptor 2B subunit gene associated with CIE-induced up-regulation of transcription. PLoS One 2010; 5: e8798.
57. Li Y, Chen G, Ma L, Ohms SJ, Sun C, Shannon MF, Fan JY. Plasticity of DNA methylation in mouse T cell activation and differentiation. BMC Mol Biol 2012; 13: 16.